Business & Consumer Services » Consumer Services | Blake Insomnia Therapeutics Inc.

Blake Insomnia Therapeutics Inc. | Balance Sheet

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2.10
1.80
9.50
4.80
0.10
107,109.52
Total Current Assets
2.10
1.80
9.50
4.80
0.10
-
Total Assets
2.10
1.80
9.50
4.80
0.10
-
ST Debt & Current Portion LT Debt
-
5.00
37.50
67.50
139.50
Other Current Liabilities
-
4.20
15.50
18.40
52.00
Total Current Liabilities
-
9.20
53.00
85.90
191.50
Total Liabilities
-
9.20
53.00
85.90
191.50
Common Equity (Total)
2.10
7.40
43.40
81.10
191.50
Total Shareholders' Equity
2.10
7.40
43.40
81.10
191.50
Total Equity
2.10
7.40
43.40
81.10
191.50
Liabilities & Shareholders' Equity
2.10
1.80
9.50
4.80
0.10

About Blake Insomnia Therapeutics

View Profile
Address
244 5th Avenue
New York New York 10001
United States
Employees -
Website http://www.blakeinsomnia.com
Updated 07/08/2019
Blake Insomnia Therapeutics, Inc. operates as a pharmaceutical company, which provides insomnia remedy. The firm has developed Zleepax, which is a sleep aid with beta blockers as the major active agent. The company was founded by Briger Jan Olsen on August 11, 2012 and is headquartered in New York, NY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.